Alternative Data for Healthcare Investors (Part IV): Claims vs EHRs

In the following Intelligence piece, we explore healthcare claims and electronic health records (EHRs) as alternative data sources for investors. Healthcare claims and EHRs can offer valuable insights into drug/medical device prescribing and utilisation trends. This information has clear applications for investors in pharmaceutical, biotech, and medical device/equipment companies as well as companies responsible for paying healthcare claims such as managed care organisations or other health insurers.


As discussed in Part I of this Neudata Intelligence series, healthcare claims and electronic health records (EHRs) are two sources of Real-World Data (RWD) (i.e. they are generated outside of controlled clinical research settings) that can be utilised by investors.

Use cases primarily revolve around the utilisation of a pharmaceutical/biotech/medical device company’s marketed products, which can be used as a proxy for product sales.

Request a Neudata free trial

We'd like to know a bit more about you and your business, so we can deal with your request efficiently.
We are committed to securing your personal information.

We use your email address as part of allowing you access to your account and in order to provide you details with our products that might be of interest to you


12 Sep 2019

Analyst Contact

Kathryn Forde Analyst (London)